Thomas Birch

Bezlotoxumab for Prevention of Recurrent <i>Clostridium difficile</i> Infection

Mark H. Wilcox, Dale N. Gerding, Ian R. Poxton et al. · New England Journal of Medicine · 2017 · 850 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

SARS and Pregnancy: A Case Report

Corwin A. Robertson, Sara A. Lowther, Thomas Birch et al. · Emerging infectious diseases · 2004 · 153 citations · Full text

Medicine, Infectious Diseases, Obstetrics +15

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study

William O’Riordan, Alison J. McManus, Jüri Teras et al. · Clinical Infectious Diseases · 2018 · 105 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacy of bezlotoxumab based on timing of administration relative to start of antibacterial therapy for Clostridium difficile infection

Thomas Birch, Yoav Golan, Giuliano Rizzardini et al. · Journal of Antimicrobial Chemotherapy · 2018 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study

Guy de Bruyn, Joyce Wang, Annie Purvis et al. · EClinicalMedicine · 2023 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17